SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Dr. Ing. h.c. F. Porsche AG (DRPRF) trades at a trailing P/E of 98.1, forward P/E of 22.7. Trailing earnings yield is 1.02%, forward earnings yield 4.41%. PEG 0.07 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (15/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 98.1).
- Forward P/E 22.7 (down from trailing 98.1) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.07 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 1.02% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 4.41% as earnings recover.
Overall SharesGrow Score: 39/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
15/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — DRPRF
Valuation Multiples
P/E (TTM)98.1
Forward P/E22.7
PEG Ratio0.07
Forward PEG0.07
P/B Ratio0.00
P/S Ratio1.16
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.47
Forward EPS (Est.)$2.03
Book Value / Share$0.00
Revenue / Share$39.81
FCF / Share$0.00
Yields & Fair Value
Earnings Yield1.02%
Forward Earnings Yield4.41%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.50 |
$1M |
$1.37B |
137400% |
| 2017 |
$3.63 |
$3.39B |
$3.28B |
96.7% |
| 2018 |
$3.78 |
$25.78B |
$3.11B |
12.1% |
| 2019 |
$4.80 |
$28.52B |
$2.8B |
9.8% |
| 2020 |
$2.85 |
$28.7B |
$3.16B |
11% |
| 2021 |
$4.43 |
$33.14B |
$4.57B |
13.8% |
| 2022 |
$5.98 |
$37.64B |
$5.49B |
14.6% |
| 2023 |
$16.64 |
$40.53B |
$5.1B |
12.6% |
| 2024 |
$3.91 |
$40.08B |
$3.59B |
9% |
| 2025 |
$0.47 |
$36.27B |
$431M |
1.2% |
